Future viral vectors for the delivery of asymptomatic herpes epitope-based immunotherapeutic vaccines
- PMID: 21442030
- PMCID: PMC3063648
- DOI: 10.2217/fvl.10.44
Future viral vectors for the delivery of asymptomatic herpes epitope-based immunotherapeutic vaccines
References
-
- Smith GL, Mackett M, Moss B. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature. 1983;302:490–495. - PubMed
-
- Draper SJ, Heeney JL. Viruses as vaccine vectors for infectious diseases and cancer. Nat. Rev. Microbiol. 2010;8:62–73. - PubMed
-
- Barzon L, Zanusso M, Colombo F, Palu G. Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas. Cancer Gene Ther. 2006;13:539–554. - PubMed
-
- BenMohamed L, Wechsler SL, Nesburn AB. Lipopeptide vaccines – yesterday, today, and tomorrow. Lancet Infect. Dis. 2002;2:425–431. - PubMed
-
- La Rosa C, Wang Z, Lacey SF, et al. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara. Exp. Hematol. 2006;34(4):497–507. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources